Skip to main content

Support Patient Access to Tests Used to Diagnose Parkinson’s

A drug that contains a radioactive substance, known as a diagnostic radiopharmaceutical, can help health care providers diagnose and determine the severity of diseases like Parkinson’s. But these drugs are not available to all Parkinson's patients. Urge Congress to expand access now.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.